Back to Search
THOMAS KAUFMAN, MD
MD
Clinical Ethicist
NPI: 1487916375Individual
Specialties, Licenses & Credentials
Clinical EthicistPrimary
Clinical Ethicist
Code: 174V00000X
MD00018011(WA)
Research & Publications (20)
The GBV-C envelope glycoprotein E2 does not interact specifically with CD81.
PMID 17457101·AIDS·2007
7-preclinical
Mycobacterium tuberculosis-infected human macrophages exhibit enhanced cellular adhesion with increased expression of LFA-1 and ICAM-1 and reduced expression and/or function of complement receptors, FcgammaRII and the mannose receptor.
PMID 12368450·Microbiology (Reading)·2002
8-other
Inactivation of Mycobacterium tuberculosis mannosyltransferase pimB reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death.
PMID 19318518·Glycobiology·2009
8-other
PCA-CR analysis of dissolution profiles. A chemometric approach to probe the polymorphic form of the active pharmaceutical ingredient in a drug product.
PMID 19477254·Int J Pharm·2009
4-observational
Emergency legal preparedness for hospitals and health care personnel.
PMID 19491586·Disaster Med Public Health Prep·2009
8-other
Centrosomin: a complex mix of long and short isoforms is required for centrosome function during early development in Drosophila melanogaster.
PMID 19528326·Genetics·2009
7-preclinical
Polytene chromosomal maps of 11 Drosophila species: the order of genomic scaffolds inferred from genetic and physical maps.
PMID 18622037·Genetics·2008
7-preclinical
Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan.
PMID 18784076·J Biol Chem·2008
8-other
Validated stability-indicating HPLC method for the determination of pridinol mesylate. Kinetics study of its degradation in acid medium.
PMID 18922659·J Pharm Biomed Anal·2008
8-other
Addressing health inequities: a case for implementing primary health care.
PMID 19005107·Can Fam Physician·2008
8-other
Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease.
PMID 18353766·Mol Cell Proteomics·2008
4-observational
Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.
PMID 18338745·Cancer·2008
3-trial
Method development and validation for the simultaneous determination of meloxicam and pridinol mesylate using RP-HPLC and its application in drug formulations.
PMID 17961953·J Pharm Biomed Anal·2008
4-observational
A new principal component analysis-based approach for testing "similarity" of drug dissolution profiles.
PMID 18394869·Eur J Pharm Sci·2008
8-other
A multivariate approach for the simultaneous determination of losartan potassium and hydrochlorothiazide in a combined pharmaceutical tablet formulation.
PMID 18528688·Anal Bioanal Chem·2008
8-other
Proteome response to the panneural expression of human wild-type alpha-synuclein: a Drosophila model of Parkinson's disease.
PMID 18683964·J Proteome Res·2008
7-preclinical
Protein expression in a Drosophila model of Parkinson's disease.
PMID 17203978·J Proteome Res·2007
7-preclinical
Discovery of functional elements in 12 Drosophila genomes using evolutionary signatures.
PMID 17994088·Nature·2007
4-observational
Alternative and improved method for the simultaneous determination of fexofenadine and pseudoephedrine in their combined tablet formulation.
PMID 17766076·J Pharm Biomed Anal·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 404 HARTMAN ST SE
TUMWATER, WA 98501 - Phone
- (360) 786-6817
Quick Facts
- NPI
- 1487916375
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile